Virax Biolabs Group Limited (VRAX)

NASDAQ

$1,95

$-0,01

(-0,46%)

Pre-Market

Virax Biolabs Group Limited (VRAX) Live Price Chart

Last updated: ⁦2026-10-09 09:35:00⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Virax Biolabs Group Limited (VRAX) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1,95, with a market capitalization of $1,68M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1,83 to $21,75. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1,68M
Open	$1,96
Day's High	$7.250,00
Day's Low	$1,83
Previous Close	$1,99
Volume	214,00
Average Volume	633,10K
P/E Ratio	--
52-Week High	$21,75
52-Week Low	$1,83
Dividend Yield	--
Earnings Date	--

Virax Biolabs Group Limited (VRAX) Pre-Market Stock Price

Virax Biolabs Group Limited (VRAX) is trading at $1,95 in pre-market trading as of 2026-10-09 09:20:00, down 2,21% ($0,04) from the previous close of $1,99

Pre-market trading shows how investors are pricing VRAX before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Virax Biolabs Group Limited (VRAX) 7-Day Stock Price Change

Over the past seven days, Virax Biolabs Group Limited (VRAX) moved from $2,18 to $1,95, representing a decline of 10,90% ($0,24).

The stock traded between $1,83 and $3,34 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 514,76 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

VRAX 52-Week Price Position

Position in Range: 0,6%

52W Low$1,83

52W High$21,75

VRAX is currently trading at $1,95, placing it 0,6% of the way from its 52-week low of $1,83 to its 52-week high of $21,75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Virax Biolabs Group Limited (VRAX)?

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Virax Biolabs Group Limited Information

Employees	26
Exchange	NASDAQ
Company Website	https://www.viraxbiolabs.com

How to Buy Virax Biolabs Group Limited (VRAX) Stock on MEXC

Eligible investors can buy real shares of Virax Biolabs Group Limited (VRAX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VRAX and Place Your Order

Open the RealStocks trading page and search for VRAX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Virax Biolabs Group Limited (VRAX) stock price today?

Virax Biolabs Group Limited (VRAX) is currently trading at $ 1,95, down 2,21% ($0,04) from the previous close of $ 1,99. Intraday prices update in real time during regular trading hours.

2.Is VRAX stock going up or down today?

As of 2026-10-09 09:20:00, VRAX is trading at $ 1,95, down 2,21% ($0,04) from its previous close of $ 1,99. The stock has traded between $ 1,83 and $ 7.250,00 during today’s regular session. Past price movements do not guarantee future results.

3.What is VRAX pre-market price?

As of 2026-10-09 09:20:00, VRAX is trading at $ 1,95 in pre-market trading, down 2,21% ($0,04) from the previous close of $ 1,99. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VRAX after-hours price?

As of 2026-10-09 09:20:00, VRAX is trading at $ 1,96 in after-hours trading, down 1,76% ($0,03) from the regular-session close of $ 1,99. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VRAX stock trading now?

VRAX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VRAX sit relative to its 52-week high and low?

Over the past 52 weeks, VRAX has traded between a low of $ 1,83 and a high of $ 21,75. At $ 1,95, the stock is positioned 0,6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Virax Biolabs Group Limited in?

Virax Biolabs Group Limited (VRAX) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Virax Biolabs Group Limited's market capitalization and where is it listed?

Virax Biolabs Group Limited is listed on the NASDAQ exchange with a market capitalization of $ 1,68M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VRAX valued in terms of P/E ratio and EPS?

VRAX trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Virax Biolabs Group Limited pay a dividend?

Virax Biolabs Group Limited pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.